{
    "Trade/Device Name(s)": [
        "Steripath\u00ae Micro Blood Collection System"
    ],
    "Submitter Information": "Magnolia Medical Technologies, Inc.",
    "510(k) Number": "K222299",
    "Predicate Device Reference 510(k) Number(s)": [
        "K200661"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JKA",
        "FPA"
    ],
    "Summary Letter Date": "November 30, 2022",
    "Summary Letter Received Date": "October 31, 2022",
    "Submission Date": "October 28, 2022",
    "Regulation Number(s)": [
        "21 CFR 862.1675"
    ],
    "Regulation Name(s)": [
        "Blood Specimen Collection Device"
    ],
    "Analyte Class(es)": [
        "misc"
    ],
    "Analyte(s)": [],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [
        "Syringe",
        "Transfer Adapter",
        "Culture bottle (not provided)"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Mechanical initial specimen diversion and sequestration"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Specimen collection device"
    ],
    "Document Summary": "FDA 510(k) summary for Steripath Micro Blood Collection System, a mechanical blood specimen collection device with diversion feature to reduce blood culture contamination.",
    "Indications for Use Summary": "Indicated for blood collection for in vitro diagnostic testing, diverts and sequesters initial specimen prior to subsequent sample to reduce frequency of blood culture contamination compared to standard procedure without manual diversion; some components may be used for infusion after sample collection.",
    "fda_folder": "Clinical Chemistry"
}